bladder cancer
Bicycle Therapeutics to Advance Zelenectide Pevedotin in NECTIN4-Amplified Cancers
The firm plans to launch trials to study the agent in biomarker-defined cancer types, including breast and lung cancers.
Leapfrog Bio to Begin Phase II Trial of Synthetic Lethal Candidate in Solid Tumors
The firm aims to start a Phase II trial in 2025 for its investigational BET inhibitor and test it in cancers with EP300 loss-of-function mutations.
Telix Pharmaceuticals to License FAP-Targeting Radiopharmaceuticals From German Researchers
The firm is paying €7 million to add fibroblast activation protein-targeting assets to its pipeline, which it will initially develop for bladder cancer.
UK Consortium Launches With Public-Private Funding to ID Immunotherapy Biomarkers
The Francis Crick Institute and the Royal Marsden Foundation Trust are spearheading the MANIFEST project with £21.9 million in government and industry funding.
Informed Genomics, NHS to Study Use of Urine-Based Bladder Cancer Test
Studies planned for this year will be used to evaluate the accuracy of Informed Genomics' Galeas Bladder test and further studies are planned for early 2025.
Apr 5, 2024
Mar 14, 2024
Aug 23, 2023